PV Bulletin
TGAAustralia

Unapproved ibutamoren capsules (MK-677) found to contain undisclosed anabolic steroid

TGA warns that unapproved ibutamoren capsules (MK-677) contain an undisclosed anabolic steroid, posing serious health risks.

Primary source: https://www.tga.gov.au/news/safety-alerts/unapproved-ibutamoren-capsules-mk-677-found-contain-undisclosed-anabolic-steroid

PV Impact Brief

Urgency: HighConfidence: high

What changed

TGA published a safety alert warning that unapproved ibutamoren capsules (MK-677) contain an undisclosed anabolic steroid.

Why it matters

The presence of an undisclosed anabolic steroid poses serious health risks, including potential adverse effects from unregulated ingredients.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Action needed

Consumers must stop taking the product immediately and return remaining capsules to a pharmacy for safe disposal.

Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Regulatory action details

Action type
Safety Alert
Publication date
2026-06-04
Safety issue
Unapproved ibutamoren capsules (MK-677) were found to contain an undisclosed anabolic steroid, posing serious health risks.

Affected products

  • Ibutamoren capsules (MK-677)

PV internal implications

Consumers should stop taking the product immediately and take any remaining capsules to their local pharmacy for safe disposal.

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 4, 2026

Full briefing

Practical implication

Consumers must stop taking the product immediately and return remaining capsules to a pharmacy for safe disposal.

The TGA issued a safety alert on 4 June 2026 regarding unapproved ibutamoren capsules (MK-677) found to contain an undisclosed anabolic steroid. Consumers are advised to stop use immediately and dispose of remaining capsules at a pharmacy.

What changed: TGA published a safety alert warning that unapproved ibutamoren capsules (MK-677) contain an undisclosed anabolic steroid.

Why it matters: The presence of an undisclosed anabolic steroid poses serious health risks, including potential adverse effects from unregulated ingredients.

Practical implication: Consumers must stop taking the product immediately and return remaining capsules to a pharmacy for safe disposal.

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

#Safety Signals#Safety Alert#TGA#other#firecrawl-agent#regulatory-extraction

Related updates for your role

publicEuropean Medicines Agency · EU · Updated Jul 15, 2026

Reflection paper on particulars for safety signals for (traditional) herbal medicinal products

Urgency: High

Implement increased documentation and reporting processes for traditional herbal medicinal products. Ensure staff receive training on the complexities involved in signal management for these products.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead
verifiedRegulatory action: Draft Guidance
Read impact briefarrow_forward
publicSwissmedic · Switzerland · Updated Jul 17, 2026

Checklist for the Inspection of Medical Device Vigilance in Hospitals

Urgency: High

Healthcare facilities must utilize the new checklist during inspections to conduct gap analyses and ensure compliance with reporting requirements associated with their vigilance systems.

Inspection ReadinessRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Checklist
Read impact briefarrow_forward
publicEuropean Medicines Agency · EU · Updated Jul 15, 2026

Updated eCTD v4.0 technical validation criteria

Urgency: High

All electronic PV submissions must undergo new validation checks in accordance with the updated criteria to ensure compliance and accuracy.

Country ComplianceICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Technical Guidance
Read impact briefarrow_forward
publicHealth Canada · Canada · Updated Jul 15, 2026

Order Providing for Reliance on Foreign Regulatory Authority Decisions for Certain Drugs (Ministerial Reliance Order)

Urgency: High

Manufacturers must demonstrate that any variances from the foreign authorized drugs do not adversely affect safety or effectiveness when filing for deeming under this new framework.

Country ComplianceSignal ManagementRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead, QPPV
verifiedRegulatory action: Draft Guidance
Read impact briefarrow_forward